| Application no. and date | 05754754.9 (espacenet) (Federated) (European Patent Register), 20050525 | | Patent/reg. no. and date | DK/EP 1761266, 20130508 | | Publication date | 20070314 | | Priority no. and date | US 574142 P, 20040525, US 853585, 20040525 | | EP pub. no. and date |
EP 1761266 20070314 | | Effective date | | | Applicant/owner | Galderma Pharma S.A., World Trade Center
Avenue Gratta-Paille 1
1000 Lausanne 30 Grey, CH | | Applicant ref. no. | P012165EPDK1 EJ/GB | | Inventor | DEJOVIN, Jack A., 2 Taylor Drive
New Brunswick, New Jersey 08901-1515, US,
ROSSI, Thomas M., 104 Sandy Ridge Mount Airy Rd.
Stockton, New Jersey 08559-2009, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K | | Opponent | | | IPC Class | A61K 31/4164 (2006.01) , A61K 31/498 (2006.01) , A61P 17/00 (2006.01) | | Title | Forbindelser, formuleringer og fremgangsmåder til at behandle eller forebygge inflammatoriske hudsygdomme | | Int. application no. | US2005018288 | | Int. publication no. | WO2005115395 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
